Ecuadorian Granadilla

Ecuadorian Granadilla (Passiflora quadrangularis L.) is rich in bioactive compounds like polyphenols and flavonoids, which contribute to its significant antioxidant properties. These compounds primarily exert their effects by activating the Keap1-Nrf2 pathway, enhancing cellular defense against oxidative stress.

Origin & History

Ecuadorian Granadilla (Passiflora ligularis) is a sweet, aromatic fruit native to the Andean region of South America, particularly Ecuador, and cultivated in high-altitude tropical areas. This delicate superfruit is prized for its soothing properties and rich nutrient profile, supporting digestive comfort and cardiovascular health.

Historical & Cultural Context

Ecuadorian Granadilla has been a staple fruit in Andean cultures for centuries, valued not only for its delicious flavor but also for its traditional medicinal properties. It is particularly used for promoting digestive health, boosting immunity, and enhancing skin vitality within these indigenous practices.

Health Benefits

- Provides digestive support with its high fiber content, promoting regularity and soothing the gastrointestinal tract.
- Promotes heart health by supplying potassium and antioxidants, contributing to blood pressure regulation and cardiovascular wellness.
- Boosts immune function through its vitamin C and antioxidant content, enhancing cellular defense.
- Enhances skin health by providing essential vitamins and antioxidants, supporting cellular regeneration and vitality.
- Reduces oxidative stress via its antioxidant compounds, protecting cells from free radical damage and supporting overall cellular integrity.

How It Works

Compounds like polyphenols and flavonoids in Ecuadorian Granadilla activate the Keap1-Nrf2 pathway. This activation occurs by disrupting Keap1's interaction with Nrf2, allowing Nrf2 to translocate to the nucleus. Once in the nucleus, Nrf2 upregulates the expression of genes encoding various antioxidant and detoxifying enzymes, thereby enhancing the cell's endogenous defense mechanisms against oxidative stress.

Scientific Research

Preliminary research, including nutritional analyses and some in vitro studies, suggests Ecuadorian Granadilla's potential for digestive support, immune enhancement, and skin health. These benefits are largely attributed to its rich content of fiber, vitamin C, and various antioxidants.

Clinical Summary

Clinical evidence on Ecuadorian Granadilla (Passiflora quadrangularis L.) is predominantly based on nutritional analyses and in vitro studies. Preliminary research indicates its rich content of polyphenols, flavonoids (e.g., 1.53 mg CatEq/g fresh weight), and carotenoids contributes to significant antioxidant activity. These findings suggest potential benefits for digestive support, immune function, and cellular protection against oxidative stress. However, comprehensive human clinical trials are needed to confirm these effects and establish optimal dosages and long-term safety.

Nutritional Profile

- Fiber
- Vitamin C
- Potassium
- Antioxidants, Essential fatty acids

Preparation & Dosage

- Traditionally consumed fresh, in juices, desserts, and traditional remedies.
- For general wellness, consume 1–2 servings of fresh fruit or juice daily for digestive health, immune support, and skin nourishment.

Synergy & Pairings

Role: Polyphenol/antioxidant base
Intention: Immune & Inflammation | Cardio & Circulation
Primary Pairings: Turmeric (Curcuma longa), Camu Camu, Ginger (Zingiber officinale), Maca Root (Lepidium meyenii)

Safety & Interactions

Ecuadorian Granadilla (Passiflora quadrangularis L.) is generally considered safe for consumption as a food item. Specific safety data, including detailed side effect profiles or drug interactions, are limited in scientific literature. As with any fiber-rich fruit, excessive consumption might lead to mild digestive upset in sensitive individuals. Pregnant and breastfeeding individuals should consume it in moderation as part of a balanced diet, consulting a healthcare provider if concerns arise, due to the lack of specific safety studies in these populations.